Publication Date
8-2023
Disclaimer
These guidelines do not establish a standard of care to be followed in every case. It is recognized that each case is different and those individuals involved in providing health care are expected to use their judgment in determining what is in the best interests of the patient based on the circumstances existing at the time. It is impossible to anticipate all possible situations that may exist and to prepare guidelines for each. Accordingly, these guidelines should guide care with the understanding that departures from them may be required at times.
Objective of the Clinical Pathway
To provide care standards for the newborn patient ≥ 35 weeks gestational age and guide the provider on screening, risk assessment, monitoring, and treatment of newborns at risk of developing hyperbilirubinemia.
Target Users
Neonatologists; Newborn nursery providers; Hospitalists; Primary care pediatricians; Emergency Medicine providers; Advanced Practice Nurses; Residents and fellows
Disciplines
Pediatrics
Recommended Citation
Children's Mercy Kansas City, "Hyperbilirubinemia" (2023). Clinical Pathways.
https://scholarlyexchange.childrensmercy.org/clinical_pathways/1
Comments
Finalized: Aug 2023